Exosomes as biomarkers and therapeutic measures for ischemic stroke

被引：0

作者：

Shi, Yun ^{[1
]}

Wang, Ruirui ^{[1
]}

Wang, Lei ^{[1
,2
,3
,4
]}

Liu, Qing ^{[1
]}

Han, Lan ^{[1
,2
]}

Duan, Xianchun ^{[1
]}

Zhang, Yanchun ^{[1
]}

Shen, Aizong ^{[5
]}

Peng, Daiyin ^{[1
,2
,4
,6
]}

Chen, Weidong ^{[1
,2
,4
,6
,7
]}

Ji, Zhaojie ^{[1
]}

机构：

[1] Anhui Univ Chinese Med, Coll Pharm, Hefei 230012, Peoples R China

[2] MOE, Anhui Joint Collaborat Innovat Ctr Qual Improvemen, Hefei, Peoples R China

[3] Anhui Acad Chinese Med, Inst Pharmaceut, Hefei, Peoples R China

[4] Anhui Prov Key Lab Chinese Med Formula, Hefei, Peoples R China

[5] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Pharm, Div Life Sci & Med, Hefei, Peoples R China

[6] Inst Tradit Chinese Med Resources Protect & Dev, Hefei, Peoples R China

[7] Anhui Prov Key Lab Tradit Chinese Med Decoct Piece, Hefei, Peoples R China

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2023年 / 939卷

基金：

中国国家自然科学基金;

关键词：

Exosomes; Ischemic stroke; Biomarkers; Therapeutic measures; CELL-DERIVED EXOSOMES; NEURAL STEM-CELLS; EXTRACELLULAR VESICLES; FUNCTIONAL RECOVERY; CIRCULATING MICRORNAS; REPERFUSION INJURY; DELIVERY-SYSTEMS; MOUSE-BRAIN; PROTECT; DISEASE;

D O I：

10.1016/j.ejphar.2022.175477

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Ischemic stroke (IS) is the leading cause of long-term disability in the world and characterized by high morbidity, recurrence, complications, and mortality. Due to the lack of early diagnostic indicators, limited therapeutic measures and inadequate prognostic indicators, the diagnosis and treatment of IS remains a particular challenge at present. It has recently been reported that exosomes (EXOs) play a significant role in the pathogenesis and treatment of IS. The purpose of this paper is to probe the role of EXOs in diagnostic biomarkers and therapeutic measures for IS and to provide innovative ideas for improving the prognosis of IS.

引用

页数：12

共 50 条

[31] Therapeutic Strategy for Ischemic Stroke
Yamashita, Toru
Deguchi, Kentaro
Sehara, Yoshihide
Lukic-Panin, Violeta
Zhang, Hanzhe
Kamiya, Tatsushi
Abe, Koji
NEUROCHEMICAL RESEARCH, 2009, 34 (04) : 707 - 710
[32] Therapeutic Strategy for Ischemic Stroke
Toru Yamashita
Kentaro Deguchi
Yoshihide Sehara
Violeta Lukic-Panin
Hanzhe Zhang
Tatsushi Kamiya
Koji Abe
Neurochemical Research, 2009, 34 : 707 - 710
[33] Therapeutic management of ischemic stroke
Bindal, Priya
Kumar, Vishal
Kapil, Lakshay
Singh, Charan
Singh, Arti
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (05) : 2651 - 2679
[34] microRNA as a therapeutic for ischemic stroke
Todoran, Raluca
Falcione, Sarina R.
Clarke, Michael
Joy, Twinkle
Boghozian, Roobina
Jickling, Glen C.
NEUROCHEMISTRY INTERNATIONAL, 2023, 163
[35] Exosomal miRNAs as Biomarkers of Ischemic Stroke
Ciaccio, Anna Maria
Tuttolomondo, Antonino
BRAIN SCIENCES, 2023, 13 (12)
[36] Angiogenesis Biomarkers in Ischemic Stroke Patients
Alrafiah, Aziza
Alofi, Ebtisam
Almohaya, Yasser
Hamami, Abdullah
Qadah, Talal
Almaghrabi, Safa
Hakami, Nora
Alrawaili, Moafaq S.
Tayeb, Haythum O.
JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 4893 - 4900
[37] Early serum biomarkers of ischemic stroke
Zivkovic, Miroslava
Ljubisavljevic, Srdjan
VOJNOSANITETSKI PREGLED, 2011, 68 (01) : 68 - 72
[38] Utility of Exosomes in Ischemic and Hemorrhagic Stroke Diagnosis and Treatment
Lee, Eun Chae
Ha, Tae Won
Lee, Dong-Hun
Hong, Dong-Yong
Park, Sang-Won
Lee, Ji Young
Lee, Man Ryul
Oh, Jae Sang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
[39] Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets
Wang, Chen
Li, Zhelong
Liu, Yunnan
Yuan, Lijun
THERANOSTICS, 2021, 11 (08): : 3996 - 4010
[40] Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
Mosquera-Heredia, Maria, I
Morales, Luis C.
Vidal, Oscar M.
Barcelo, Ernesto
Silvera-Redondo, Carlos
Velez, Jorge, I
Garavito-Galofre, Pilar
BIOMEDICINES, 2021, 9 (08)

← 1 2 3 4 5 →